All Companies
JNJCongressional Stock Trades
Johnson & Johnson
Pharmaceutical Preparations
Congressional stock trades in Johnson & Johnson (JNJ) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
53
Politicians Trading
21
Last Traded
Aug 27, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ro KhannaD | Aug 7, 2026 | Jul 20, 2026 | Buy | $1,001 - $15,000 | +8.51% |
| Lloyd DoggettD | Jan 2, 2026 | Dec 9, 2025 | Buy | $1,001 - $15,000 | +35.02% |
| Lloyd DoggettD | Jul 7, 2025 | Jun 10, 2025 | Buy | $1,001 - $15,000 | +72.57% |
| Gilbert Ray Cisneros, Jr.D | Jun 6, 2025 | May 30, 2025 | Buy | $15,001 - $50,000 | +73.95% |
| Gilbert Ray Cisneros, Jr.D | Apr 7, 2025 | Mar 31, 2025 | Buy | $15,001 - $50,000 | +62.80% |
| Lloyd DoggettD | Apr 7, 2025 | Mar 4, 2025 | Buy | $1,001 - $15,000 | +63.21% |
| Josh GottheimerD | Feb 10, 2025 | Jan 24, 2025 | Buy | $1,001 - $15,000 | +83.89% |
| Josh GottheimerD | Feb 10, 2025 | Jan 21, 2025 | Buy | $1,001 - $15,000 | +82.24% |
| Josh GottheimerD | Feb 10, 2025 | Jan 16, 2025 | Buy | $1,001 - $15,000 | +82.71% |
Price History
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.